It has been demonstrated that stimulation of TLR3 drives breast cancer cells toward a cancer stem cell phenotype, which requires simultaneous activation of the β-catenin and NF-κB signaling pathway, implying a cooperative and synergistic function of β-catenin in TLR3-activated NF-κB signaling (47). The gene discussed is NFKB1; the disease is breast cancer.